• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Longeveron Inc (NQ: LGVN )

    2.450 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 71,056
    Open 2.450
    Bid (Size) 2.390 (7)
    Ask (Size) 2.400 (1)
    Prev. Close 2.450
    Today's Range 2.450 - 2.450
    52wk Range 0.3313 - 5.470
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    Peering Into Longeveron's Recent Short Interest
    Via Benzinga

    Performance

    YTD
    +85.61%
    +85.61%
    1 Month
    +105.88%
    +105.88%
    3 Month
    +528.21%
    +528.21%
    6 Month
    +96.00%
    +96.00%
    1 Year
    -31.75%
    -31.75%

    More News

    Read More
    3 Penny Stocks Poised to Turn Pocket Change Into a Small Fortune by 2028
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why Is Longeveron (LGVN) Stock Up 120% Today?
    Via InvestorPlace
    Life Sciences Virtual Investor Forum Agenda Announced for June 20th
    From Virtual Investor Conferences
    Via GlobeNewswire
    InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Exercise Warrants for $4.4M, Present at Virtual Life Sciences Investor Forum
    Via Investor Brand Network
    Exposures Product Safety
    Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase
    Via FinancialNewsMedia
    Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase
    From FN Media Group LLC
    Via GlobeNewswire
    Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    What's Going On With Longeveron Stock?
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Why Is Cara Therapeutics (CARA) Stock Down 27% Today?
    Via InvestorPlace
    Why Is Assure (IONM) Stock Down 53% Today?
    Via InvestorPlace
    Why Broadcom Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why Is Longeveron (LGVN) Stock Up 46% Today?
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    Why Are Longeveron Shares Trading Higher Wednesday?
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Announces CEO Participation in Emerging Growth Conference, Completion of Investigator Meeting for Phase 2b Clinical Trial
    Via Investor Brand Network
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.